Farrell D F, Sumi S M, Scott C R, Rice G
J Neurol Neurosurg Psychiatry. 1978 Jan;41(1):76-82. doi: 10.1136/jnnp.41.1.76.
Galactosylceramide beta-galactosidase activity was assayed in cultured amniotic fluid cells from two pregnancies at risk for Krabbe's leucodystrophy. The elective termination of one pregnancy was carried out after demonstration of a severe deficiency of galactosylceramide beta-galactosidase activity. The diagnosis of Krabbe's leucodystrophy in the affected fetus was confirmed enzymatically by a deficiency of galactosylceramide beta-galactosidase inbrain, liver, kidney, and cultured skin fibroblasts, and histologically by the ultrastructural demonstration of the typical intracellular inclusions in cells of the spinal cord.
在来自两个存在患克拉伯病(Krabbe 病)风险的妊娠案例的羊水培养细胞中检测了半乳糖神经酰胺β - 半乳糖苷酶活性。在证实半乳糖神经酰胺β - 半乳糖苷酶活性严重缺乏后,对其中一个妊娠案例进行了选择性终止妊娠。通过检测脑、肝、肾和培养的皮肤成纤维细胞中半乳糖神经酰胺β - 半乳糖苷酶缺乏,酶学上确诊了受影响胎儿的克拉伯病,并且通过脊髓细胞中典型细胞内包涵体的超微结构证明,组织学上也确诊了该病。